This study analyzed the potential roles of plasma asprosin in healthy, T2DM, and PCOS females and demonstrated that plasma asprosin increased in patients with PCOS and was associated with various metabolic parameters and sex-related hormone profiles. This evidence concerns the gene FBN1 and polycystic ovary syndrome.